NGD-4715

From WikiMD's WELLNESSPEDIA

NGD-4715 is a chemical compound that is being studied for its potential therapeutic uses. It is a GABA (gamma-aminobutyric acid) modulator that has been shown to have potential in the treatment of anxiety disorders and insomnia.

Chemistry[edit]

NGD-4715 is a small molecule that acts as a modulator of the GABA system. GABA is the primary inhibitory neurotransmitter in the human brain, and alterations in GABA signaling have been implicated in a number of neurological and psychiatric disorders. NGD-4715 is believed to enhance GABA signaling, which could potentially have therapeutic effects in conditions characterized by excessive neuronal activity, such as anxiety and insomnia.

Pharmacology[edit]

The exact mechanism of action of NGD-4715 is not fully understood, but it is believed to work by enhancing the activity of GABA, the primary inhibitory neurotransmitter in the brain. This can have a calming effect on the nervous system, which may help to reduce symptoms of anxiety and promote sleep.

Clinical Trials[edit]

NGD-4715 has been studied in a number of clinical trials for its potential use in the treatment of anxiety disorders and insomnia. While the results of these trials have been promising, further research is needed to fully understand the potential benefits and risks of this compound.

Potential Therapeutic Uses[edit]

The primary potential therapeutic uses of NGD-4715 are in the treatment of anxiety disorders and insomnia. Anxiety disorders are characterized by excessive worry and fear, while insomnia is characterized by difficulty falling asleep or staying asleep. Both conditions are believed to be related to alterations in GABA signaling, and NGD-4715, as a GABA modulator, could potentially help to normalize this signaling and reduce symptoms.

Safety and Side Effects[edit]

As with any drug, NGD-4715 has the potential to cause side effects. The most common side effects reported in clinical trials include dizziness, fatigue, and nausea. However, these side effects were generally mild and temporary. More research is needed to fully understand the safety profile of NGD-4715.

See Also[edit]


This Chemical compound-related article is a stub. You can help WikiMD by expanding the page.

This article is a stub related to pharmacology. You can help WikiMD by expanding it!


  • NGD-4715
    NGD-4715

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=NGD-4715&oldid=6335257"